Akebia Therapeutics (AKBA) Total Debt (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Total Debt of $48.9 million for Q1 2026, up 5.11% year-over-year from $46.5 million in Q1 2025, and up 1.33% quarter-over-quarter from $48.2 million in Q4 2025.
Akebia Therapeutics (AKBA) Total Debt (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Total Debt for 9 consecutive years, with $48.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 5.11% year-over-year to $48.9 million; the TTM figure through Mar 2026 stood at $48.9 million (up 5.11% YoY), while the FY2025 annual figure was $48.2 million, up 24.7% from the prior year.
- Total Debt advanced to $48.9 million in Q1 2026 per AKBA's latest filing, from $48.2 million in the prior quarter.
- Across five years, Total Debt topped out at $196.3 million in Q2 2022 and bottomed at $30.1 million in Q1 2024.
- Historically, Total Debt has averaged $61.5 million across 5 years, with a median of $47.1 million in 2025.
- Annual changes were most pronounced in 2022 — Total Debt soared 102.56% — and 2023, when it sank 78.36%.
- Akebia Therapeutics' Total Debt stood at $66.1 million in 2022, then tumbled by 47.51% to $34.7 million in 2023, then climbed by 11.56% to $38.7 million in 2024, then rose by 24.7% to $48.2 million in 2025, then climbed by 1.33% to $48.9 million in 2026.
- Business Quant data shows AKBA's Total Debt at $48.9 million in Q1 2026, $48.2 million in Q4 2025, and $47.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 74.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.37 Mn |
| Mar 31, 2026 | 48.89 Mn |
| Dec 31, 2025 | 48.25 Mn |
| Sep 30, 2025 | 47.64 Mn |
| Jun 30, 2025 | 47.06 Mn |
| Mar 31, 2025 | 46.51 Mn |
| Dec 31, 2024 | 38.69 Mn |
| Sep 30, 2024 | 38.36 Mn |
| Jun 30, 2024 | 38.03 Mn |
| Mar 31, 2024 | 30.15 Mn |
| Dec 31, 2023 | 34.68 Mn |
| Sep 30, 2023 | 42.61 Mn |
| Jun 30, 2023 | 42.49 Mn |
| Mar 31, 2023 | 50.30 Mn |
| Dec 31, 2022 | 66.08 Mn |
| Sep 30, 2022 | 131.89 Mn |
| Jun 30, 2022 | 196.32 Mn |
| Mar 31, 2022 | 97.85 Mn |
| Dec 31, 2021 | 97.54 Mn |
| Sep 30, 2021 | 97.23 Mn |